These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17512433)

  • 1. A pathologist's perspective on emerging genomic tests for breast cancer.
    Symmans WF
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding tumor profiling and assessing treatment.
    Hyams DM
    Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the science: molecular classifications of breast cancer for clinical diagnostics.
    Robison JE; Perreard L; Bernard PS
    Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative biology: a new paradigm for tumor profiling, prognosis, and treatment.
    Heaton AH
    Manag Care; 2008 Jul; 17(7 Suppl 7):3; discussion 17-8. PubMed ID: 19097281
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing therapeutically developed assays.
    Kolesar JM
    Manag Care; 2008 Jul; 17(7 Suppl 7):9-12; discussion 17-8. PubMed ID: 19097282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling.
    Hicks DG; Kushner L; McCarthy K
    J Natl Cancer Inst Monogr; 2011; 2011(42):43-5. PubMed ID: 21672896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer.
    Pusztai L; Gianni L
    Nat Clin Pract Oncol; 2004 Nov; 1(1):44-50. PubMed ID: 16264799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in breast cancer.
    Nasser SM
    J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generation of molecular prognostic and predictive tests for breast cancer.
    Pusztai L; Cristofanilli M; Paik S
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review).
    Chuthapisith S; Eremin JM; Eremin O
    Oncol Rep; 2008 Oct; 20(4):699-703. PubMed ID: 18813806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A health plan's integration of molecular diagnostics and the impact on treatment pathways for quality care.
    Wong W
    Manag Care; 2008 Jul; 17(7 Suppl 7):13-6; discussion 17-8. PubMed ID: 19093337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis from tissue core biopsies: standard of care for the future?
    Sarkar S; Tuck DP; Harris LN
    Breast Cancer Res Treat; 2009 Dec; 118(3):645-6. PubMed ID: 19234784
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic medicine. Gene expression tests foretell breast cancer's future.
    Garber K
    Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
    Nagasaki K; Miki Y
    Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercialized multigene predictors of clinical outcome for breast cancer.
    Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
    Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.